Shuo Shi

43PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Pattern recognitionMolecular targetsElectrochemical energy storage and conversionSoftware and application security
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Sep 02, 2026
MYC-Sensitized Cuproptosis Combined With PTT to Remodel the Immune Microenvironment of Prostate Cancer.

|Dec 31, 2025
Multi-Molecular Logic Framework Based on Morse Code, ASCII Logic, and Beale's Cipher for Advanced Crypto-Steganography.

Mohamed Nabeel Mattath, Yingying Lu, Ajith Manayil Parambil

|Dec 29, 2025
ADAMTS9-AS2 Disrupts Docetaxel-Resistance in Castration-Resistant Prostate Cancer via Stemness Suppression and Ferroptosis Induction.

Ji Liu, Yan Gao, Yadong Guo

|Jul 12, 2025
Correction: Ye et al. The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer. Cancers 2022, 14, 2101.

Pingting Ye, Lei Feng, Shuo Shi

|Jun 11, 2025
A PROTAC-Based Cuproptosis Sensitizer in Lung Cancer Therapy.

Yu Wang, Xiaoyang Yao, Yingying Lu

|May 28, 2025
Pyroptosis-Inducing Platinum(IV) Prodrugs via GSDME Pathway for Chemoimmunotherapy and Metastasis Inhibition in Triple-Negative Breast Cancer.

Xinda Yang, Chuansheng Xu, Youliang Zeng

Pageof 8

Frequent Collaborators

9 joint publications

Chunyan Dong

4 joint publications

Tianming Yao

4 joint publications

Thimmaiah Govindaraju

4 joint publications

Mohamed Nabeel Mattath